allicin has been researched along with Metabolic Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aparicio Trejo, OE; Arellano Buendia, AS; Argüello-García, R; Bojalil, R; García-Arroyo, F; Juárez Rojas, JG; Osorio-Alonso, H; Sánchez-Lozada, LG; Sánchez-Muñoz, F | 1 |
| Hosseini, A; Hosseinzadeh, H | 1 |
| Mirelman, D; Miron, T; Oron-Herman, M; Rabinkov, A; Rosenthal, T; Sela, BA; Wilchek, M | 1 |
| Ernsberger, P; Johnson, JL; Koletsky, RJ; Mirelman, D; Rosenthal, T | 1 |
1 review(s) available for allicin and Metabolic Syndrome
| Article | Year |
|---|---|
A review on the effects of Allium sativum (Garlic) in metabolic syndrome.
Topics: Animals; Antihypertensive Agents; Disulfides; Garlic; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Metabolic Syndrome; Sulfinic Acids | 2015 |
3 other study(ies) available for allicin and Metabolic Syndrome
| Article | Year |
|---|---|
Antioxidant and anti-inflammatory effects of allicin in the kidney of an experimental model of metabolic syndrome.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Glucose Intolerance; Inflammation; Kidney; Male; Metabolic Syndrome; Models, Theoretical; Rats; Rats, Wistar; Renal Insufficiency, Chronic | 2023 |
The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cyclopropanes; Disease Models, Animal; Disulfides; Homocysteine; Hypertension; Hypoglycemic Agents; Insulin; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Risk Factors; Sulfinic Acids; Treatment Outcome; Triglycerides | 2005 |
Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Disease Models, Animal; Disulfides; Dose-Response Relationship, Drug; Drug Combinations; Female; Hypoglycemic Agents; Insulin; Male; Metabolic Syndrome; Rats; Rats, Inbred SHR; Sulfinic Acids; Treatment Outcome | 2007 |